Orthopedic Clinics of North America · Published 2026-07-01 · DOI 10.1016/j.ocl.2026.05.004
Maxwell Trudeau, Olivia Schaffer, Ran Schwarzkopf
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Trudeau, M., Schaffer, O., Schwarzkopf, R. (2026). Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis. Orthopedic Clinics of North America. https://doi.org/10.1016/j.ocl.2026.05.004